Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW -- Ignore unavailable to you. Want to Upgrade?

To: Mama Bear who wrote (563)	11/5/1998 12:53:00 PM
From: Anthony@Pacific	Respond to of 857

I for one think asensio is an arrogant and idiotic trader if he believes that disclosing his short-interest will do any thing but cause the " Short buster type trader" to take a whack at forcing a squeeze...which we have seen,, the company on the other hand are even bigger criminals and have defacated all over the FDA process and the discretion they are supposed to exhibit..Ampligen is clearly a useless and ineffective drug which HEB has no exclusivity to control; This published report still holds true... dripadvisor.com The points made about the orphan drug status are very much true and if any real market actually ever developed HEB would have this revoked,, by the way anyone have an idea as to when we might see the Phase 3 trials near completion..It is in the best interest of the Company to never finish them...so they can keep the stock afloat. Asensio has done a true dis-service to himself and those who know and believe this is a complete scam.

To: Mama Bear who wrote (563)	11/5/1998 1:16:00 PM
From: Marty	Read Replies (2) \| Respond to of 857

"Well, whether you believe it or not you are incorrect, and your submission has been proven to be false." If you believe I am incorrect, give me your authority as to why you think so. I gave you the basis for my opinion. BTW, " … your submission has been proven to be false" is written in the passive voice… the structure purposely avoids the question of "WHO proved it false?" "Short selling is an inherently short term trade by it's (sic) very nature" There is nothing that makes a short sale inherently short term. You could stay with a profitable short sale as long as you wanted. Tax treatment is another matter. However, as long it is short-term tax treatment, why not let it run as long as it is profitable? The typical staying period for shorts, in my opinion based on personal experience, is more in the inherent risk and basic nature of most short sellers. They typically pull the trigger a lot sooner. I am ready to re-consider what I saw first hand over an extended period if you are able to produce an authoritative study that concludes that short sales have the same average holding period as the average long holding period. You should be ready to re-consider as well, if you can't produce the documentation. Consider yourself lucky that you weren't able to borrow HEB shares to short. Dr. Carter of HEB cut off sources of illegal short sales as just one counter tactic in his defense of the stock price. He has also effectively responded to the misstatements in the Asensio "analysis" as well as suing him for them. Besides that HEB has an effective drug and lots of potential in other areas. You should read the Security Capital report on it.